Clinical Intelligence/Clinical Efficiency

Zynx Health announce a strategic partnership with LogicStream Health

Firms Integrate Technology for Advanced Capability to Analyze Content, Improve Clinical Processes, and Drive Better Performance

Zynx Health, a pioneer and market leader in evidence- and experience-based clinical solutions, today announced a strategic partnership with LogicStream Health, a leading clinical data and clinical intelligence firm. The company said the partnership is focused on delivering advanced performance improvement capabilities to health systems across the United States. The two companies have already begun rolling out this joint solution to customers.

“As a pioneer in the industry and for more than a quarter of a century, Zynx Health has consistently evolved its solutions to provide best-in-class content, analytics and performance improvement tools to hospitals and health systems,” said Charles Tuchinda, MD, president of Zynx Health. “The integration of LogicStream Health’s sophisticated clinical data and intelligence software with our product portfolio is the next step in advancing the way clinical teams improve patient outcomes by directly measuring and recommending enhancements to the interventions they order.”

“LogicStream, since its founding in 2013, has been focused on delivering timely, data-driven insights about areas for improvement and reduced variation in clinical process and workflows to frontline clinical teams,” said Patrick Yoder, PharmD, CEO of LogicStream. “We are excited about joining forces with Zynx Health to help customers achieve meaningful and measurable improvements in clinical, operational and financial performance.”

Visit AITechPark for cutting-edge Tech Trends around AI, ML, Cybersecurity, along with AITech News, and timely updates from industry professionals!

Related posts

CirrusMD launches New Model of Care “Physician-first Care & Guidance”

GlobeNewswire

BioIntelliSense Launches Pulse Oximetry (SpO2) Sensor Technology

GlobeNewswire

Iktos and Facio Therapies Collab to Use AI for FSHD Drug Design

Business Wire